Dietary berries and ellagic acid diminish estrogen-mediated mammary tumorigenesis in ACI rats

Nutrition and Cancer

Volumn 60, Issue 2, 2008, Pages 227-234

  Aiyer, Harini S ^a   Srinivasan, Cidambi ^b   Gupta, Ramesh C ^c,d  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c University of Louisville School of Medicine   (United States)

^d UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELLAGIC ACID; ESTRADIOL; ESTROGEN;

ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLUEBERRY; BREAST CANCER; BREAST CARCINOGENESIS; CANCER INCIDENCE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; FEMALE; NONHUMAN; PALPATION; RASPBERRY; RAT; TUMOR VOLUME;

ANIMALS; CELL PROLIFERATION; ELLAGIC ACID; ESTRADIOL; FEMALE; FRUIT; MAMMARY NEOPLASMS, EXPERIMENTAL; RANDOM ALLOCATION; RATS; RATS, INBRED ACI; TIME FACTORS;

ANIMALIA; RATTUS; RUBUS OCCIDENTALIS; VACCINIUM;

EID: 41449110727     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580701624712     Document Type: Article

References (54)

1. American Cancer Society. Breast Cancer Facts and Figures-2007. Atlanta, GA: American Cancer Society; 2007.
2. Silverstein MJ, Poller DN, Waisman JR, Colburn WJ, Barth A, et al.: Prognostic classification of breast ductal carcinoma-in-situ. Lancet 345, 1154-1157, 1995.
3. Lippman ME, Krueger KA, Eckert S, Sashegyi A, Walls EL, et al.: Indicators of lifetime estrogen exposure: effect on breast cancer incidence and interaction with raloxifene therapy in the multiple outcomes of raloxifene evaluation study participants. J Clin Oncol 19, 3111-3116, 2001.
4. Verheul HA, Coelingh-Bennink HJ, Kenemans P, Atsma WJ, Burger CW, et al.: Effects of estrogens and hormone replacement therapy on breast cancer risk and on efficacy of breast cancer therapies. Maturitas 36, 1-17, 2000.
5. Dunning WF, Curtis MR, and Segaloff A. Strain differences in response to estrone and the induction of mammary gland, adrenal, and bladder cancer in rats. Cancer Res 13, 147-152, 1953.
6. Gullino PM, Pettigrew HM, and Grantham FH. N-nitrosomethylurea as mammary gland carcinogen in rats. J Natl Cancer Inst 54, 401-414, 1975.
7. Huggins C, Briziarelli G, and Sutton H Jr: Rapid induction of mammary carcinoma in the rat and the influence of hormones on the tumors. J Exp Med 109, 25-42, 1959.
8. Shepel LA and Gould MN: The genetic components of susceptibility to breast cancer in the rat. Prog Exp Tumor Res 35, 158-169, 1999.
9. Thompson HJ, Adlakha H, and Singh M: Effect of carcinogen dose and age at administration on induction of mammary carcinogenesis by 1-methyl-1- nitrosourea. Carcinogenesis 13, 1535-1539, 1992.
10. Adamovic T, Roshani L, Chen L, Schaffer BS, Helou K, et al.: Nonrandom pattern of chromosome aberrations in 17beta-estradiol-induced rat mammary tumors: indications of distinct pathways for tumor development. Genes Chromosomes Cancer 46, 459-469, 2007.
11. Li JJ, Papa D, Davis MF, Weroha SJ, Aldaz CM, et al.: Ploidy differences between hormone- and chemical carcinogen-induced rat mammary neoplasms: comparison to invasive human ductal breast cancer. Mol Carcinog 33, 56-65, 2002.
12. Li JJ, Weroha SJ, Lingle WL, Papa D, Salisbury JL, et al.: Estrogen mediates Aurora-A overexpression, centrosome amplification, chromosomal instability and breast cancer in female ACI rats. Proc Natl Acad Sci U S A 101, 18123-18128, 2004.
13. Schaffer BS, Lachel CM, Pennington KL, Murrin CR, Strecker TE, et al.: Genetic bases of estrogen-induced tumorigenesis in the rat: mapping of loci controlling susceptibility to mammary cancer in a Brown Norway x ACI intercross. Cancer Res 66, 7793-7800, 2006.
14. Gould KA, Tochacek M, Schaffer BS, Reindl TM, Murrin CR, et al.: Genetic determination of susceptibility to estrogen-induced mammary cancer in the ACI rat: mapping of Emca1 and Emca2 to chromosomes 5 and 18. Genetics 168, 2113-2125, 2004.
15. Strecker TE, Spady TJ, Schaffer BS, Gould KA, Kaufman AE, et al.: Genetic bases of estrogen-induced pituitary tumorigenesis: identification of genetic loci determining estrogen-induced pituitary growth in reciprocal crosses between the ACI and Copenhagen rat strains. Genetics 169, 2189-2197, 2005.
16. Ravoori S, Vadhanam MV, Sahoo S, Srinivasan C, and Gupta RC: Mammary tumor induction in ACI rats exposed to low levels of 17β-estradiol. Int J Oncol 31, 113-120, 2007.
17. Weroha SJ, Li SA, Tawfik O, and Li JJ: Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats. Carcinogenesis 27, 491-498, 2006.
18. Block G, Patterson B, and Subar A: Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 18, 1-29, 1992.
19. Hercberg S. The history of beta-carotene and cancers: from observational to intervention studies. What lessons can be drawn for future research on polyphenols? Am J Clin Nutr 81(1Suppl), 218S-222S, 2005.
20. Forman MR, Hursting SD, Umar A, and Barrett JC: Nutrition and cancer prevention: a multidisciplinary perspective on human trials. Annu Rev Nutr 24, 23-54, 2004.
21. United States Department of Agriculture. Recommended Dietary Intakes. 〈http://fnic.nal.usda.gov/nal display/index.php?info center=4&tax level= 3&tax subject=256&topic id=1342&level3 id=5140&level4 id=0&level5 id=0&placement default=0〉. June 20, 2007.
22. Blumberg J and Block G: The alpha-tocopherol, beta-carotene cancer prevention study in Finland. Nutr Rev 52, 242-245, 1994.
23. Block G: Are clinical trials really the answer? Am J Clin Nutr 62(6Suppl), 1517S-1520S, 1995.
24. Meyskens FL Jr and Szabo E: Diet and cancer: the disconnect between epidemiology and randomized clinical trials. Cancer Epidemiol Biomarkers Prev 14, 1366-1369, 2005.
25. Daniel EM, Krupnick AS, Heur Y, Blinzler JA, Nims RW, et al.: Extraction, stability and quantitation of ellagic acid in various fruits and nuts. J Food compos Anal 2338-2349, 1989.
26. Oregon Berry Comission: Berry Health Brochures. http://www.oregonberries.com/.
27. United States Department of Agriculture: USDA National Nurtient Database. http://www.nal.usda.gov/fnic/foodcomp.
28. Wu X, Beecher GR, Holden JM, Haytowitz DB, Gebhardt SE, et al.: Concentrations of anthocyanins in common foods in the United States and estimation of normal consumption. J Agric Food Chem 54, 4069-4075, 2006.
29. Maas J, Galletta G, and Stoner GD: Ellagic acid, an anticarcinogen in fruits, especially strawberries. Hort Science 26, 10-14, 1991.
30. Aggarwal BB and Shishodia S: Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71, 1397-1421, 2006.
31. Stoner GD and Mukhtar H: Polyphenols as cancer chemopreventive agents. J Cell Biochem 22(Suppl), 169-180, 1995.
32. Larrosa M, Tomas-Barberan FA, and Espin JC: The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway. J Nutr Biochem 17, 611-625, 2006.
33. Harris GK, Gupta A, Nines RG, Kresty LA, Habib SG, et al.: Effects of lyophilized black raspberries on azoxymethane-induced colon cancer and 8-hydroxy-2′-deoxyguanosine levels in the Fischer 344 rat. Nutr Cancer 40, 125-133, 2001.
34. Kresty LA, Morse MA, Morgan C, Carlton PS, Lu J, et al.: Chemoprevention of esophageal tumorigenesis by dietary administration of lyophilized black raspberries. Cancer Res 61, 6112-6119, 2001.
35. Stoner GD, Chen T, Kresty LA, Aziz RM, Reinemann T, et al.: Protection against esophageal cancer in rodents with lyophilized berries: potential mechanisms. Nutr Cancer 54, 33-46, 2006.
36. Lau FC, Shukitt-Hale B, and Joseph JA: The beneficial effects of fruit polyphenols on brain aging. Neurobiol Aging 26(1Suppl), 128-132, 2005.
37. Yi W, Fischer J, Krewer G, and Akoh CC: Phenolic compounds from blueberries can inhibit colon cancer cell proliferation and induce apoptosis. J Agric Food Chem 53, 7320-7329, 2005.
38. Seeram NP, Adams LS, Henning SM, Niu Y, Zhang Y, et al.: In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J Nutr Biochem 16, 360-367, 2005.
39. Mandal S and Stoner GD: Inhibition of N-nitrosobenzylmethylamine-induced esophageal tumorigenesis in rats by ellagic acid. Carcinogenesis 11, 55-61, 1990.
40. Shull JD, Spady TJ, Snyder MC, Johansson SL, and Pennington KL: Ovary-intact, but not ovariectomized female ACI rats treated with 17beta-estradiol rapidly develop mammary carcinoma. Carcinogenesis 18, 1595-1601, 1997.
41. Hampton T: Clinical trials point to complexities of chemoprevention for cancer. JAMA 294, 29-31, 2005.
42. Wada L and Ou B: Antioxidant activity and phenolic content of Oregon caneberries. J Agric Food Chem 50, 3495-3500, 2002.
43. Wang SY and Lin HS: Antioxidant activity in fruits and leaves of blackberry, raspberry, and strawberry varies with cultivar and developmental stage. J Agric Food Chem 48, 140-146, 2000.
44. Chen T, Hwang H, Rose ME, Nines RG, and Stoner GD: Chemopreventive properties of black raspberries in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis: down-regulation of cyclooxygenase-2, inducible nitric oxide synthase, and c-Jun. Cancer Res 66, 2853-2859, 2006.
45. Hecht SS, Huang C, Stoner GD, Li J, Kenney PM, et al.: Identification of cyanidin glycosides as constituents of freeze-dried black raspberries which inhibit anti-benzo[a]pyrene-7,8-diol-9,10-epoxide induced NFkappaB and AP-1 activity. Carcinogenesis 27, 1617-1626, 2006.
46. Han DH, Lee MJ, and Kim JH: Antioxidant and apoptosis-inducing activities of ellagic acid. Anticancer Res 26, 3601-3606, 2006.
47. Seeram NP, Adams LS, Zhang Y, Lee R, Sand D, et al.: Blackberry, black raspberry, blueberry, cranberry, red raspberry, and strawberry extracts inhibit growth and stimulate apoptosis of human cancer cells in vitro. J Agric Food Chem 54, 9329-9339, 2006.
48. Hirose M, Akagi K, Hasegawa R, Yaono M, Satoh T, et al.: Chemoprevention of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine (PhIP)-induced mammary gland carcinogenesis by antioxidants in F344 female rats. Carcinogenesis 16, 217-221, 1995.
49. Singletary K and Liao CH: Ellagic acid effects on the carcinogenicity, DNA-binding and metabolism of 7,12-dimethylbenz(a)anthracene (DMBA). In Vivo 3, 173-175, 1989.
50. Larrosa M, Gonzalez-Sarrias A, Garcia-Conesa MT, Tomas-Barberan FA, and Espin JC: Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities. J Agric Food Chem 54, 1611-1620, 2006.
51. Schmitt E and Stopper H: Estrogenic activity of naturally occurring anthocyanidins. Nutr Cancer 41, 145-149, 2001.
52. Carlton PS, Kresty LA, Siglin JC, Morse MA, Lu J, et al.: Inhibition of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus by dietary freeze-dried strawberries. Carcinogenesis 22, 441-446, 2001.
53. Li SA, Weroha SJ, Tawfik O, and Li JJ: Prevention of solely estrogen-induced mammary tumors in female aci rats by tamoxifen: evidence for estrogen receptor mediation. J Endocrinol 175, 297-305, 2002.
54. Mesia-Vela S, Sanchez RI, Reuhl KR, Conney AH, and Kauffman FC: Phenobarbital treatment inhibits the formation of estradiol-dependent mammary tumors in the August-Copenhagen Irish rat. J Pharmacol Exp Ther 317, 590-597, 2006.